Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6408 posts found.

iannone

Immunomedics’ whirlwind in the C-suite continues

April 10, 2018 Manufacturing and Production, Medical Communications AstraZeneca, Immunomedics, Seattle Genetics, biotech, drugs, pharma, pharmaceutical

Immunomedics hasn’t had the most straight forward year, its $2 billion deal with Seattle Genetics was scuppered by activist investors, …
News
fighting_cancer

Looking to the future of oncology

April 9, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CAR T, CAR-T, Cancer, feature, oncology, pharma

The oncology field moves so quickly that it can be hard to keep track of the latest innovations. Ben Hargreaves …
Feature
800px-prostate_cancer_1

Almost 40% of UK prostate cancer cases are diagnosed late, according to report

April 9, 2018 Medical Communications, Research and Development, Sales and Marketing Cancer, UK, pharma, prostate cancer

A report conducted by charity Orchid has revealed a “worrying trend” in the treatment of prostate cancer, indicating that as …
News
instagram-3198093_960_720

Facebook takes action against drug peddlers on Instagram

April 9, 2018 Medical Communications, Sales and Marketing Facebook, biotech, drugs, fentanyl, instagram, opioid, opioid epidemic, pharma, pharmaceutical

Facebook can’t catch a break at the moment, after being widely criticised for its practices over the security of users’ …
News
humira_abbott__4

Samsung Bioepis and Biogen secure licensing deal with Abbvie for Humira biosimilar

April 6, 2018 Medical Communications, Sales and Marketing AbbVie, Biogen, Humira, Imraldi, Samsung Bioepis, biosimilar, pharma

Partners Biogen and Samsung Bioepis have secured the future of their Humira (adalimumab) biosimilar after penning a deal with Abbvie …
News
top_ten

Top Ten most popular articles on Pharmafile.com this week

April 6, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, Boehringer Ingelheim, Kite, Nordic Nanovector, Pfizer, Roche, Sanofi, biotech, cystic fibrosis, drugs, pharma, pharmaceutical

Some of the biggest news this week concerns companies that are looking to move on parts of their business, but …
News
roche_close

Roche suffers Ocrevus knockback by NICE

April 6, 2018 Medical Communications, Sales and Marketing Ocrevus, Roche, biotech, drugs, multiple sclerosis, pharma, pharmaceutical

Roche’s multiple sclerosis drug, Ocrevus (ocrelizumab), has been a big new growth driver for the company, especially in the US, …
News
shutterstock_274590824

J&J pays out $37m in damages over claims its talc contains asbestos

April 6, 2018 Medical Communications, Sales and Marketing Cancer, J&J, JJ, Johnson & Johnson, mesothelioma, ovarian cancer, pharma, talc

Bad news for Johnson & Johnson as it emerges that the US pharma giant has been ordered to pay out …
News
china_block_001_takeda

Takeda move for Shire looks increasingly likely

April 6, 2018 Medical Communications, Sales and Marketing Japan, Shire, Takeda, UK, biotech, drugs, pharma, pharmaceutical

Takeda’s surprise announcement, just last week, that it was weighing up a move for Shire had some analysts sceptical about …
News
luigi_costa_credit_nordic_nanovector_headshot

Nordic Nanovector CEO steps down as company delays R&D timelines

April 5, 2018 Medical Communications, Research and Development, Sales and Marketing Luigi Costa, Nordic Nanovector, pharma

Norwegian biopharmaceutical firm Nordic Nanovector has revealed that its Chief Executive Officer Luigi Costa is set to step down from …
News
cystic_fibrosis_insider_interview

Transforming cystic fibrosis treatment

April 5, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Vertex, biotech, cystic fibrosis, drugs, pharma, pharmaceutical

Fred van Goor, Principle Research Fellow at Vertex Pharmaceuticals, discusses his history of work in cystic fibrosis and how the …
Feature
sugar

Obesity admissions double in four years

April 5, 2018 Medical Communications NHS, UK, biotech, drugs, pharma, pharmaceutical

New figures show that hospital admissions related to obesity have doubled over the last four years in the UK, placing …
News
beam

Proton beam therapy finally arrives in UK

April 4, 2018 Medical Communications, Research and Development NHS, Proton beam therapy, biotech, drugs, pharma, pharmaceutical

28 years after the US first pioneered proton beam therapy at Loma Linda University Medical Center, the UK now has …
News

Patient experience: Living with ovarian cancer

April 3, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Ingrid Copperman, feature, ovarian cancer, patient experience, pharma

Ingrid Copperman recounts the many ways she has dealt with her diagnosis, as well as how the power of social …
Feature

One centre for cancer diagnoses trialled

April 3, 2018 Manufacturing and Production, Medical Communications, Sales and Marketing NHS, biotech, drugs, pharma, pharmaceutical

NHS England is trialling centres that should be able to provide rapid answers as to whether a patient has cancer …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026